AI assistant
Repare Therapeutics Inc. — Director's Dealing 2021
Mar 15, 2021
34365_dirs_2021-03-15_d99b01a8-48de-4792-9d97-b486ec672eeb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Repare Therapeutics Inc. (RPTX)
CIK: 0001808158
Period of Report: 2021-03-12
Reporting Person: Foley Todd (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-12 | Common Shares | S | 376412 | $28.18 | Disposed | 2627360 | Indirect |
| 2021-03-15 | Common Shares | J | 24271 | — | Disposed | 2603089 | Indirect |
Footnotes
F1: The shares were sold as follows: 363,887 by MPM BioVentures 2014, L.P. ("BV 2014") and 12,525 by MPM Asset Management Investors BV2014 LLC ("AM BV2014").
F2: The shares are held as follows: 2,364,040 by BV 2014, 181,948 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)") and 81,372 by AM BV2014. MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). BV LLC is the manager of AM BV2014. Todd Foley is a managing director of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F3: Represents a pro rata in-kind distribution from BV 2014(B) to its limited partners for no consideration.
F4: The shares are held as follows: 2,364,040 by BV 2014, 157,677 by BV 2014(B) and 81,372 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.